Potent and selective PTDSS1 inhibitors induce collateral lethality in cancers with PTDSS2 deletion
Significance This study identifies a specific dependency on PTDSS1 for phosphatidylserine synthesis following PTDSS2 deletion and introduces novel PTDSS1 inhibitors as a therapeutic option to induce collateral lethality in cancer with PTDSS2 loss.